Related Experiment Videos
Genetics of prostate cancer
Kai Qi Zhang1, Sherry A Salzman, D J Reding
1Personalized Medicine Research Center, Marshfield Medical Research Foundation, Marshfield, Wisconsin 54449, USA.
Clinical Medicine & Research
|June 3, 2005
Summary
This study investigated genetic factors in prostate cancer by scanning genomes of affected families. Genes KIAA 0872 and 17-beta hydroxysteroid dehydrogenase on chromosome 16 were analyzed and found unlikely to cause familial prostate cancer.
Area of Science:
- Genetics
- Oncology
- Genomics
Background:
- Prostate cancer is a leading cause of cancer death in men.
- Identifying genetic predispositions is crucial for understanding and treating prostate cancer.
- Previous studies suggested chromosomal regions linked to prostate cancer risk and aggressiveness.
Purpose of the Study:
- To identify genes predisposing to prostate cancer.
- To analyze specific genes within a mapped region on chromosome 16 for mutations.
- To assess the role of KIAA 0872 and 17-beta hydroxysteroid dehydrogenase in familial prostate cancer.
Main Methods:
- Whole genome scan of affected sib pairs using DNA markers.
- DNA sequence analysis of KIAA 0872 and 17-beta hydroxysteroid dehydrogenase.
- Examination of protein coding regions and splice junction sites for mutations.
Main Results:
- Whole genome scan identified potential susceptibility regions on chromosomes 1, 4, 5, 7, 8, 11, 16, and 19.
- No mutations were found in the protein coding regions or splice junctions of KIAA 0872.
- No mutations were found in the protein coding regions or splice junctions of 17-beta hydroxysteroid dehydrogenase.
Conclusions:
- KIAA 0872 and 17-beta hydroxysteroid dehydrogenase are unlikely to be major contributors to familial prostate cancer.
- Further research is needed to identify the specific genes responsible for prostate cancer predisposition in the identified chromosomal regions.